Drug recall · January 14, 2015
HydrALAZINE Hydrochloride Tablets recall
Why: Presence of Foreign Substance: Par Pharmaceutical, Inc. is recalling one lot of HydrALAZINE Hydrochloride tablets due to the presence of small aluminum particles.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
HydrALAZINE Hydrochloride Tablets, USP 25 mg, 100 count bottle Rx only, Distributed by: Par Pharmaceutical Companies, Inc. Spring Valley, NY10977
- Lots / codes
Lot 26708501, Exp. 01/17
- Quantity
- 38,788 bottles
- Company
- Par Pharmaceutical Inc., Spring Valley, NY
- Distribution
- Nationwide
- Initiated
- November 24, 2014 · Voluntary: Firm initiated
- Classified
- January 6, 2015
- Reported
- January 14, 2015
- Ended
- May 1, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydralazine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.